REGISTERED
on 25 Apr 2023
Last Applicant/ Owned by
SUITE 6990
WOBURN
MA
01801
Serial Number
88641428 filed on 03rd Oct 2019
Registration Number
7037386 registered on 25th Apr 2023
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
AXIAL THERAPEUTICS
Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids; Read More
Classification Information
Class [001]
Chemical Products
Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic or microbe-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic or microbe-targeted pharmaceutical preparations for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
First Use Date in General
01st Oct 2022
First Use Date in Commerce
01st Oct 2022
Class [005]
Pharmaceutical Products
Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
First Use Date in General
20th Dec 2021
First Use Date in Commerce
20th Dec 2021
Class [042]
Computer & Software Services & Scientific Services
Providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic or microbe-targeted phamaceutical products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others
First Use Date in General
24th Oct 2021
First Use Date in Commerce
24th Oct 2021
Class [044]
Medical, Beauty & Agricultural Services
Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic or microbe-targeted pharmaceuticals
First Use Date in General
24th Oct 2021
First Use Date in Commerce
24th Oct 2021
Mark Details
Serial Number
No 88641428
Mark Type
No Service Mark
Attorney Docket Number
No AXLB.012T
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Apr 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 25th Apr 2023 | REGISTERED-PRINCIPAL REGISTER |
| 21st Mar 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 18th Mar 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 22nd Feb 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 21st Feb 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 21st Feb 2023 | SOU EXTENSION 2 GRANTED |
| 17th Feb 2023 | USE AMENDMENT FILED |
| 17th Feb 2023 | SOU EXTENSION 2 FILED |
| 17th Feb 2023 | TEAS EXTENSION RECEIVED |